ARCHIVES

DCT Advisors Approve Increased Spending On Trials Monitoring

This article is from The Cancer Letter archive.

Vol. 20 No. 18 | May 6, 1994

Download PDF Visit The Full Archive

Related Articles

Program Project Guidelines Available

October 27, 1995

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990

Health Organizations: Cancer Center, Organization Join to Promote Awareness Of Skin Cancer

April 11, 1997

Report on Carcinogens: Advisors Recommend Tobacco, UV Light, Tamoxifen, For Report

November 7, 1997

Expiring Program Offer Flexibility

February 12, 1982

Oncology Nurse “Cinderella’s” Need Specialty Status

November 23, 1974